PCSK9 inhibitor overcomes muscle-related statin intolerance

CHICAGO – Statin-associated muscle symptoms are real for roughly 40% of patients with a history of this adverse effect, and for such patients who are truly unable to tolerate a statin treatment, a...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news